News Novimmune files rare disease drug in EU, after selling rights to Sobi Richard Staines Novimmune, Rare diseases, SOBI 0 Comment Deal could be worth more than $450 million Share X Novimmune files rare disease drug in EU, after selling rights to Sobi https://pharmaphorum.com/news/novimmune-files-emapalumab/